Home Reforming the male Tanner genital scale
Article Open Access

Reforming the male Tanner genital scale

  • Peter Lauffer , Christiaan F. Mooij , Nitash Zwaveling-Soonawala and A.S. Paul van Trotsenburg EMAIL logo
Published/Copyright: February 12, 2020

Dear Editor,

The Tanner scale, used to asses pubertal stage in children, was first described by J.M. Tanner and R.H. Whitehouse in 1955 [1]. For boys, it consisted of genital (G) and pubic hair (P) stages 1 to 5. Description of the genital development stage (G) included growth and changes of the penis, scrotum and testes. In a longitudinal study on pubertal development of 228 boys living in a children’s home (the Harpenden Growth Study), the age of arrival at these different genital and pubic hair stages were accurately assessed and described [2]. In a later study, reanalysing data from the British 1965 growth study [3], Tanner reshaped the genital stages into penis stages (excluding testes) and showed at which ages a testis volume of 4 mL and 12 mL was attained [4]. The testicular volumes were measured with the Prader orchidometer, which was introduced in 1966 [5]. In this study, the 50th centile of both penis stage 2 and a testis volume of 4 mL was at 12 years. Accordingly, in most cases, a testis volume of 4 mL corresponds to a certain degree of pituitary-gonadal axis activation, producing enough androgens to yield genital stage 2. Hence, genital stage 2 (G2) is generally considered the first physical sign of central pituitary gonadal activation and thereby initiation of puberty. In the current male Tanner scale used by most physicians, testicular size is incorporated in Tanner stage G and an explicit subdivision of genital development stages into penis/scrotum stages and testicular size is not in practice anymore [6].

It is, however, important to realise that changes to both the testes and penis/scrotum are a result of pituitary-gonadal activation (normally), but develop by different pathways. Under the influence of androgens, there is a gradual change in the penis/scrotum and eventually testicular growth. However, testicular growth initially occurs because of follicle-stimulating hormone (FSH)-driven Sertoli cell and seminiferous tubule growth.

Because of the incorporation of testicular growth in the genital Tanner stages, pubertal assessment is prone to misclassification. A careful evaluation (and classification) of the testes and penis/scrotum separately guards the physician for diagnostic pitfalls. The following three cases illustrate why genital development stages (better: penis/scrotum stages) should be reserved for evaluating androgen production, and that the assessment of testicular size has a different purpose in physical examination.

  1. An 8-year-old boy was referred to our clinic because of premature pubarche and growth acceleration. The main diagnostic considerations were central precocious puberty, premature adrenarche and late-onset congenital adrenal hyperplasia (CAH). His Tanner stage was assessed as G3P3. The testicular volume was 2 mL. Small testes indicated an inactive pituitary-gonadal axis which ruled out central precocious puberty. Additional investigations were performed for non-central causes of precocious puberty and led to the diagnosis of late-onset CAH.

  2. A 14-year-old boy with short stature supposedly due to constitutional delay of growth and puberty was investigated by the paediatric endocrinologist. He had a Tanner stage of G3P3 and the testicular volume was 20 mL. Such testicular development was an unexpected finding, as virilisation had just recently begun. Additional blood investigation showed relatively low gonadotropin and testosterone levels. Thyroid function tests indicated central hypothyroidism, and genetic testing led to the diagnosis to IGSF1 deficiency syndrome. This explained the discrepancy between pubertal development and testicular volume as macroorchidism is a key feature of this syndrome [7].

  3. A 15-year-old boy was assessed for pubertal development and had a Tanner stage of G5P5. The testes were 6 mL and were soft upon palpation. He had a history of medulloblastoma for which he had received treatment with craniospinal irradiation and chemotherapy (cisplatin) at the age of 11 years. His plasma testosterone level was in the normal adult range. The incongruence between Tanner stage and testis volume was explained by the gonadotoxic effects of chemotherapy mainly affecting Sertoli cells (which determine testicular volume) and not Leydig cell function.

These three cases illustrate that separate classification of penile/scrotal change and testicular volume provides a more accurate description of pubertal development, especially in pathological conditions where G2 is not accompanied by a testicular volume of 4 mL and vice versa. Penile and scrotal change is a result of increasing androgen production, whereas testicular growth is a result of central activation of the pubertal axis or pathogenic IGSF1 variants. Testicular growth may be impeded by chemotherapy or primary endocrine testicular failure (with adrenal androgens promoting penile and scrotal change) such as Klinefelter syndrome (partial/stagnating virilisation and small firm testes).

The penis/scrotum and testes were still considered separately by Tanner in a 1985 longitudinal study on height and development of North American children [8]. They are nowadays joined in the genital Tanner stages. We think it is better to view these two features as distinct components of genital and pubertal development and propose to divide the current Tanner genital development stages for boys into a genital stage (penis/scrotum stage, abbreviated G) and a separately reported testis volume measurement.


Corresponding author: Prof. Dr. A.S. Paul van Trotsenburg, Department of Paediatric Endocrinology, Emma Children’s Hospital, Amsterdam University Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, the Netherlands, Phone: +3120 566 8000

Acknowledgements

None.

  1. Author contributions: All authors conceived of the presented idea. PL took the lead in writing the letter. All authors provided feedback and agreed to the submission of the final version. All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, or interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Tanner JM. Growth at adolescence. 1 ed. Oxford: Blackwell Scientific Publication; 1955.Search in Google Scholar

2. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in boys. Arch Dis Child 1970;45:13–23.10.1136/adc.45.239.13Search in Google Scholar

3. Tanner JM, Whitehouse RH, Takaishi M. Standards from birth to maturity for height, weight, height velocity, and weight velocity: British children, 1965. I. Arch Dis Child 1966;41:454–71.10.1136/adc.41.219.454Search in Google Scholar

4. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 1976;51:170–9.10.1136/adc.51.3.170Search in Google Scholar

5. Prader A. Testicular size: assessment and clinical importance. Triangle 1966;7:240–3.Search in Google Scholar

6. Klein DA, Emerick JE, Sylvester JE, Vogt KS. Disorders of puberty: an approach to diagnosis and management. Am Fam Physician 2017;96:590–9.Search in Google Scholar

7. Heinen CA, Zwaveling-Soonawala N, Fliers E, Turgeon MO, Bernard DJ, van Trotsenburg ASP. A novel IGSF1 mutation in a boy with short stature and hypercholesterolemia: a case report. J Endocr Soc 2017;1:731–6.10.1210/js.2017-00107Search in Google Scholar

8. Tanner JM, Davies PS. Clinical longitudinal standards for height and height velocity for North American children. J Pediatr 1985;107:317–29.10.1016/S0022-3476(85)80501-1Search in Google Scholar

Received: 2019-10-24
Accepted: 2020-01-04
Published Online: 2020-02-12
Published in Print: 2020-03-26

©2020 A.S. Paul van Trotsenburg et al., published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Articles in the same Issue

  1. Frontmatter
  2. Original Articles
  3. Vitamin D status in Israeli pediatric type 1 diabetes patients: the AWeSoMe Study Group experience and literature review
  4. Metabolic features and changes in glucose-induced serum glucagon-like peptide-1 levels in children with hypothalamic obesity
  5. Assessment of intima-media thickness of the carotid artery and intraluminal diameter of the brachial artery as cardiovascular risk markers in Brazilian adolescents with overweight or obesity
  6. The role of LCPUFA-ω3 on the obesity-associated hyperandrogenemia of pubertal girls: secondary analysis of a randomized clinical trial
  7. Genetic variants of the phenylalanine hydroxylase gene in patients with phenylketonuria in the northeast of Iran
  8. Oral health status of children with phenylketonuria
  9. Birth weight related blood concentrations of the neurotransmission amino acids glutamine plus glutamate, phenylalanine and tyrosine in full-term breastfed infants perinatally
  10. Hyperthyrotropinemia is common in preterm infants who are born small for gestational age
  11. Radioactive iodine therapy for pediatric Graves’ disease: a single-center experience over a 10-year period
  12. The decision-making levels of urine tetrasaccharide for the diagnosis of Pompe disease in the Turkish population
  13. A questionnaire study on sleep disturbances associated with Prader-Willi syndrome
  14. Body size measurements, digit ratio (2D:4D) and oestrogen and progesterone receptors’ expressions in juvenile gigantomastia
  15. The effect of celiac disease and gluten-free diet on pubertal development: a two-center study
  16. Observational study of disorders of sex development in Yaounde, Cameroon
  17. Letter to the Editor
  18. Reforming the male Tanner genital scale
  19. Short Communication
  20. The association between vitamin D levels and precocious puberty: a meta-analysis
  21. Case Reports
  22. Partial trisomy 9p and 14q microduplication in a patient with growth retardation: a case report and review of the literature
  23. Two different missense mutations of PEX genes in two similar patients with severe Zellweger syndrome: an argument on the genotype-phenotype correlation
  24. Patient report
  25. Marked phenotypic variable expression among brothers with duplication of Xq27.1 involving the SOX3 gene
  26. Case Report
  27. Does the risk of arterial hypertension increase in the course of triptorelin treatment?
Downloaded on 7.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2019-0501/html?lang=en&srsltid=AfmBOory2gWFpL2H72JXv5M2dYG1rH73Y6DPFu91HQXyxVT14gXNopzD
Scroll to top button